The FDA's Lola Fashoyin-Aje said the agency understands people do not want to enroll in randomized studies for rapidly progressing fatal diseases with no available therapies. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
